Abstract
We prospectively evaluated fat intake as predictor of developing breast cancer (BC) subtypes defined by ER, PR and HER2, in a large (n=337,327) heterogeneous cohort of women, with 10,062 BC cases after 11.5 years, estimating BC hazard ratios (HR) by Cox proportional hazard modeling. High total and saturated fat were associated with greater risk of ER+PR+ disease (HR:1.20; 95%CI:1.00 -1.45; HR:1.28; 95%CI:1.09-1.52, highest vs. lowest quintiles) but not ER-PR-disease. High saturated fat was statistically significantly associated with greater risk of HER2-disease. High saturated fat intake particularly increases risk of receptor-positive disease, suggesting saturated fat involvement in the etiology of this BC subtype.
The hypothesis that high fat intake increases breast cancer (BC) risk dates back to the 1970s (1), but has been persistently controversial. An extensive 2007 review (2) concluded that evidence from prospective epidemiological studies was inconsistent, while case-control studies indicate a statistically significant positive association between fat intake and BC. Our recent EPIC study (European Investigation into Cancer and Nutrition), found weak but statistically significant positive associations of saturated fat intake with BC risk (3) . The conflicting results of earlier studies are likely due to difficulties in obtaining precise estimates of fat intake, and also to limited heterogeneity of intake within geographically confined populations (4) .
BC is now classified into subtypes determined clinically by the expression of receptors for estrogen (ER), progesterone receptor (PR) and human epidermal growth factor (HER2) (5;6): the subtypes differ in prognoses and factors influencing their occurrence (5) , which may have confounded associations between fat intake and BC. The association of fat intake with risk of BC subtypes has been little studied and with conflicting results (7) (8) (9) (10) (11) .
To further investigate the effect of dietary fat on BC, we expanded the follow-up of our EPIC study (3) , prospectively evaluating associations of dietary fat with BC subtypes defined by ER, PR and HER2 status. EPIC is a prospective cohort study conducted in 10 European countries (12) The present EPIC study was conducted on 337,327 women and used multivariate Cox proportional hazard modeling to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) for developing BC in relation to fat intake (as quintiles and continuous variables), with stratification by center and age.
Non-alcohol energy, energy from alcohol, smoking, education, age at menarche, full-term pregnancy, hormone therapy use, and BMI/menopausal status interaction, were covariates.
The proportional hazards assumption for each fat and fat subtype in relation to breast cancer risk was tested using the Grambsch and Therneau method (13). In all cases, the proportional hazards assumption was satisfied. The form of the predictor in the Cox regression is linear and was tested by means of a restricted cubic spline with 5 knots (14).
To correct the dietary questionnaires for measurement errors, intake data were calibrated against highly standardized 24-hour dietary recall interviews on a random sample (8.0%) of the cohort (15;16) (See Supplementary Methods, available online, for more details). All tests of statistical significance were two-sided and a P value of less or equal to 0.05 was considered statistically significant.
After a mean of 11.5 years (359,814 person-years) 10,062 incident cases were identified. ER, PR and HER2 status, obtained from pathology reports, were available for 70.6%, 59.0%, and 22.9% of cases, respectively.
Women in the highest quintile of saturated fat intake had a statistically significantly greater risk of BC than those in the lowest quintile. Increases in total and monounsaturated fat intake (continuous variables) were also associated with greater BC risk (Supplementary Table 1 ). The association between fat intake and BC did not vary with menopausal status at baseline or at diagnosis (data not shown).
High total fat intake was positively associated with development of ER+PR+ disease (HR:1.20; 95%CI:1.00-1.45 highest vs. lowest quintile), but not ER-PR-disease, with statistically significant (P=0.05) heterogeneity between ER+PR+ and ER-PR-cancers ( Table 1) .
Women with highest quintile of saturated fat consumption had a statistically significantly greater risk of ER+PR+ BC than those in the lowest quintile (HR:1.28;95%CI:1.09-1.52), with a statistically significant trend (P=0.009). Increasing saturated fat intake (continuous variable) was also associated with greater risk of ER+PR-BC. Heterogeneity tests were not statistically significant for saturated fat.
No association of any fat type with ER-PR-disease was found. Risk estimates for ER+, ER-, PR+ and PR-BC are presented separately in Supplementary- Table 2 .
No association of any fat with HER2+ BC was found ( Table 2) . For saturated fat, all intake quintiles were associated with a statistically significantly greater risk of HER2-BC than reference (HR:
1.29; 95%CI:1.01-1.64 highest vs. lowest), with a statistically significant trend (P=0.04). Increase in monounsaturated fat intake (continuous variable) was also associated with greater risk of HER2-disease. Furthermore, heterogeneity tests comparing HER2+ with HER2-cancer were always statistically non-significant.
The results of this study support our original finding (3) that high saturated fat intake is statistically significantly associated with increased BC risk, but indicate that excess dietary fat is more strongly associated with hormone-sensitive than receptor-negative disease. Similar findings have been reported previously (7, 9, 17) , although other studies on postmenopausal women (10, 11) found no evidence that the association between dietary fat and BC varied with ER or PR status.
High lifetime exposure to estrogen (early menarche, late menopause, postmenopausal hormone therapy and postmenopausal adiposity) is more strongly associated with ER+PR+ than ER-PR-BC(5); while high endogenous sex hormone levels have also been related to the development of receptorpositive BC (18-22). It is unclear whether high dietary fat increases sex hormone levels, but this is one mechanism by which is fat could increase susceptibility to receptor-positive BC (23).
Fat intake and BC HER2 status appear not to have been investigated previously. We found positive associations between high saturated and monounsaturated fat intake and HER-BC, but no relation to HER2+ disease. HER2+ BC is aggressive and seems little influenced by hormone-related risk factors (24). Furthermore our finding of no association between any type of fat intake and HER2+ disease is consistent with the fact that HER2+ cancers typically do not express ER or PR, and do not respond to tamoxifen (25;26). Evidence suggests that factors influencing hormonal status (e.g. parity, age at menarche, age at menopause) only influence the risk of developing HER2-disease (24;26).
Our study strengths are prospective design, large proportion of cases with receptor information, and wide variation in fat intake. The main source of hormone receptor data was medical records. Although receptor status was usually determined immunohistochemically, methods used varied across laboratories resulting in some misclassification. Another concern is that women with hormone receptor information may differ from those without this information. However findings for sub-groups without ER, PR or HER2 information were similar to these with this information, suggesting no selection bias related to receptor status information.
All dietary assessment methods involve measurement error. Although the dietary questionnaires used in the various centers were similar, they differed in detail because each was designed to capture local eating habits. To compensate for errors generated by differences in dietary assessment, we corrected (calibrated) dietary data, using data 'predicted' by 24-h dietary recall.
To conclude, the results of this prospective study on a large heterogeneous population of European women indicate that a high fat diet increases BC risk and, most conspicuously, that high saturated fat intake increases risk of receptor-positive disease, suggesting saturated fat involvement in the etiology of receptor-positive BC. 
Note
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Supplementary Methods

Study Populations
EPIC is a large prospective cohort study conducted in 23 centers in Denmark (Aarhus, Copenhagen), France, Germany (Heidelberg, Potsdam), Greece, Italy (Florence, Varese, Ragusa, Turin, Naples), Norway, Spain (Asturias, Granada, Murcia, Navarra, San Sebastian), Sweden (Malmö, Umeå), The Netherlands (Bilthoven, Utrecht) and the UK (Cambridge, Oxford) (1).
Briefly, 519,978 volunteers were recruited after giving informed consent. They completed dietary and lifestyle questionnaires, and anthropometric measurements were recorded. The present study was conducted on 337,327 women after excluding those with: prevalent any site cancer at recruitment (n=19,853); lost to follow-up at time 0 (n=2,292); age outside 20-70 years (n=6,401); in situ breast cancer (n=1,398); diet and lifestyle questionnaires not completed (n=3,320); and ratio of total energy intake (determined from the questionnaire) to basal metabolic rate [determined by
Harris-Benedict equation (2)] at either extreme of the distribution (cut-offs first and last percentiles) in order to reduce the impact of implausible extreme values (n=6,764).
The study was approved by the International Agency for Research on Cancer ethical committee and the local ethical committees of the participating centers.
Data Collection
Ascertainment of cancer cases. Cases were ascertained by population-based cancer registries in seven countries (Denmark, Italy, the Netherlands, Spain, Sweden, the UK, and Norway). In France, Germany, Greece, and the Italian center of Naples, various methods were used to identify cases, including consulting national health insurance records and regional or national pathology registries;
and active follow-up (contacting participants or next-of-kin). Mortality data were obtained mostly from mortality registries at regional or national levels.
Subjects were followed-up from study entry to any cancer diagnosis (except non-melanoma skin cancer), death, emigration or end of follow-up, whichever occurred first. Dietary Assessment Diet was assessed by using country-specific (or in some cases center-specific)
dietary questionnaires designed to capture local dietary habits. Eight countries used selfadministered dietary questionnaires, whereas, in Greece, Spain, and southern Italy (Naples and Ragusa), the questionnaires were administered by interviewers. In most countries, the questionnaires were extensive quantitative instruments (containing up to 260 food items). In Denmark, Norway, Umeå (Sweden), and Naples (Italy), semi-quantitative food-frequency questionnaires (FFQs) were administered. In Malmö (Sweden), an interview-based diet history method combining a questionnaire with a 7-day menu book was used. In the UK, an FFQ and a 7-day dietary record were used, but all results are from the FFQ (5). All dietary questionnaires were validated (6).
The EPIC Nutrient Database (7) was used to convert the quantities of food consumed into daily energy and total, saturated, monounsaturated, and polyunsaturated fat intakes.
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Statistical Analyses
Multivariate Cox proportional hazard models were used to assess the association of fat intakes with breast cancer risk, with stratification by center to control for center effects, and age (1 year categories). In all models, age was the primary time variable. Because macronutrient intake correlates strongly with energy intake, we used a modified standard model (8) , which includes absolute fat intake (g) and total non-alcohol energy intake (instead of total energy intake), to adjust for the confounding effect of energy intake. We subtracted energy from alcohol from total energy intake, and included in the model as a separated covariate, in order to better adjust the model for alcohol given it is a common risk factor for breast cancer. Fat intakes were analyzed as both categorical and continuous variables. For the former, quintiles of fat intake were determined from the distribution in each receptor subset included in the analysis. Linear trends were tested by modeling the variable whose value was the number of the quintile to which the subject belonged.
When intakes of total fat and fat subtype were modeled as continuous variables, they were transformed to logarithms to the base 1.2, so that HRs represent the risk associated with a 20.0%
increase in fat intake.
The following covariates were included in the models: total energy excluding energy from alcohol (continuous),energy from alcohol (continuous), smoking status (never, former, current, unknown), educational attainment (years of schooling), age at menarche (≤11, 12-14, >14 years, missing), full-term pregnancy (yes, no, missing) and hormone replacement therapy use (ever, never, missing). Missing values (generally <2.0%) were accounted for by creating an extra category for each categorical co-variable. In order to take into account the differing effect of body mass index (BMI) on breast cancer risk in relation to menopausal status, all models were also adjusted by an interaction term between these two variables (BMI/menopausal status interaction) Menopausal status at baseline was defined as described elsewhere (9) using an algorithm that accounts for information on menstrual status/history, type of menopause, use of oral contraceptives and 4 menopausal hormones. The cut-off of 50 years of age was used as an approximate indicator of menopausal status at diagnosis (women diagnosed at ≤50 years and >50 years).
To correct FFQs for measurement errors, the intake data were calibrated against highly standardized 24-hour dietary recall (24-HDR) interviews conducted using the EPIC-soft software on a random sample (8.0%) of the cohort: a fixed-effects linear model was used in which center and sex-specific 24-HDR data were regressed on FFQ intakes (10;11).
The Q test statistic with 9 degrees of freedom was used to assess statistical heterogeneity and investigate the hypothesis that associations between dietary components and breast cancer risk were the same in all countries (12) Models investigating associations of total fat and fat subtypes with all breast cancers and with breast cancer types defined by ER status (ER+, ER-), PR status (PR+, PR-), combined ER and PR status (ER+PR+, ER+PR-, ER-PR-, ER PR unknown), and also HER2 status (HER2+, HER2-, HER2 unknown) were run. The heterogeneity of associations according to receptor status was assessed using the data augmentation method (13), in which the difference in log likelihood between a model with receptor status-specific variables and a model with a single HR estimate for the 2 categories of receptor status was compared to a chi-square distribution with 1 degree of freedom (comparison between positive and negative receptor). In these analyses, women who developed a competing breast cancer subtype or had missing receptor status, were censored at the time of occurrence.
We also examined whether the association between fat and breast cancer risk was modified by menopausal status (post-vs. pre-menopause). This was achieved by modeling product terms of the dichotomized menopausal variable multiplied by the subject's fat intake considered as a continuous variable. The statistical significance of the interaction was assessed using a likelihood ratio test that compared the models with and without the product term, to a chi-square distribution with one degree of freedom.
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In additional analyses we also examined the association between intake of total fat and fat subtypes and breast cancer risk, when breast cancer cases diagnosed in the two first years of follow up were excluded (to investigate a possible influence of subclinical disease on dietary fat). These analyses did not produce results differing from those reported in the tables and the results were not shown. 
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